A detailed history of Exane Derivatives transactions in Cushman & Wakefield PLC stock. As of the latest transaction made, Exane Derivatives holds 38,306 shares of CWK stock, worth $586,081. This represents 0.37% of its overall portfolio holdings.

Number of Shares
38,306
Previous 65,154 41.21%
Holding current value
$586,081
Previous $1.34 Million 56.36%
% of portfolio
0.37%
Previous 0.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$14.05 - $20.59 $377,214 - $552,800
-26,848 Reduced 41.21%
38,306 $583,000
Q1 2022

Apr 22, 2022

SELL
$18.74 - $23.12 $122,653 - $151,320
-6,545 Reduced 9.13%
65,154 $1.34 Million
Q4 2021

Jan 28, 2022

BUY
$17.68 - $22.47 $875,584 - $1.11 Million
49,524 Added 223.33%
71,699 $1.59 Million
Q3 2021

Oct 26, 2021

BUY
$16.1 - $19.28 $357,017 - $427,534
22,175 New
22,175 $412,000

Others Institutions Holding CWK

About Cushman & Wakefield plc


  • Ticker CWK
  • Exchange NYSE
  • Sector Real Estate
  • Industry Real Estate Services
  • Shares Outstandng 225,675,008
  • Market Cap $3.45B
  • Description
  • Cushman & Wakefield plc, together with its subsidiaries, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom, and internationally. The company operates through Americas; Europe, Middle East, and Africa; and Asia Pacific segments. It offers integrated facilities ...
More about CWK
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.